Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    "gastrointestinal stromal tumor"
Show Display Options
Rank Status Study
21 Completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Everolimus;   Drug: Imatinib
22 Active, not recruiting Symptom Inventory for Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Behavioral: Questionnaires;   Behavioral: Interview;   Behavioral: MDASI-GIST Questionnaire
23 Unknown  A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Masitinib;   Drug: Sunitinib
24 Completed
Has Results
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: Observation
25 Unknown  A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: masitinib (AB1010);   Drug: imatinib
26 Recruiting A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: sunitinib malate dose escalation;   Drug: sunitinib malate
27 Not yet recruiting A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: BBI503
28 Unknown  Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib mesylate
29 Completed
Has Results
Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AUY922
30 Completed
Has Results
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: dovitinib
31 Not yet recruiting the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Procedure: Laparoscopic endoscopy combined surgery;   Procedure: laparoscopic and endoscopic cooperative surgery;   Procedure: Single-arch laparoscopic and endoscopic cooperative surgery
32 Withdrawn Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: dovitinib plus imatinib
33 Completed Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: imatinib mesylate
34 Active, not recruiting
Has Results
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: Sorafenib Tosylate
35 No longer available Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Regorafenib (BAY73-4506)
36 Completed
Has Results
Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: SU011248
37 Completed Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
38 Completed
Has Results
A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Sunitinib malate (SU011248)
39 Completed Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: imatinib mesylate
40 Active, not recruiting
Has Results
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: regorafenib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.